human
respiratori
syncyti
viru
rsv
sometim
caus
acut
sever
lower
respiratori
tract
ill
infant
young
children
plateletactiv
factor
paf
receptor
receptor
streptococcu
pneumonia
haemophilu
influenza
upregul
rsv
infect
pulmonari
epitheli
cell
line
fosfomycin
antimicrobi
agent
significantli
suppress
paf
receptor
induct
rsv
infect
mrna
cell
surfac
express
level
fosfomycin
also
suppress
rsvinduc
adhes
fluorescencelabel
pneumonia
h
influenza
cell
determin
flow
cytometri
fluoresc
microscopi
rsvinduc
bacteri
adhes
suggest
hostpafreceptor
bacterialphosphocholin
mediat
fosfomycin
shown
exhibit
antimicrobi
immunomodulatori
activ
found
suppress
adhes
diseasecaus
bacteria
thu
fosfomycin
might
prevent
secondari
bacteri
infect
rsv
infect
human
respiratori
syncyti
viru
rsv
one
import
infecti
agent
caus
acut
lower
respiratori
tract
ill
bronchiol
pneumonia
infant
young
children
frequent
multipl
infect
respiratori
virus
includ
rsv
bacteria
caus
communityacquir
respiratori
diseas
streptococcu
pneumonia
haemophilu
influenza
evid
posit
correl
infect
pneumonia
rsv
pathogenesi
otiti
media
pneumonia
mening
kim
et
al
andrad
et
al
hament
et
al
chonmaitre
heikkinen
streptococcu
pneumonia
h
influenza
colon
host
respiratori
epithelium
via
host
cell
surfac
receptor
plateletactiv
factor
paf
receptor
cundel
et
al
cundel
et
al
sword
et
al
bacteria
interact
paf
receptor
via
phosphocholin
compon
bacteri
cell
surfac
haemophilu
influenza
lipooligosaccharid
contain
phosphocholin
carbohydr
chain
sword
et
al
enhanc
adher
live
heatkil
pneumonia
cell
observ
human
epitheli
cell
infect
rsv
hament
et
al
upregul
paf
receptor
express
induc
infect
respiratori
virus
includ
rsv
result
enhanc
adher
pneumonia
h
influenza
respiratori
epitheli
cell
ishizuka
et
al
avadhanula
et
al
paf
receptor
express
pneumonia
cell
adhes
also
upregul
exposur
acid
caus
tissu
injuri
inflammatori
respons
ishizuka
et
al
antimicrobi
agent
fosfomycin
variou
applic
indic
includ
upper
lower
respiratori
infecti
diseas
japan
european
countri
countri
wherea
current
indic
limit
urinari
tract
infect
unit
state
fosfomycin
inhibit
biosynthesi
nacetylneuramin
acid
earli
step
peptidoglycan
synthesi
fosfomycin
share
broadspectrum
antibacteri
activ
synergist
activ
variou
antibiot
includ
blactam
review
popov
et
al
addit
antibacteri
activ
fosfomycin
suggest
immunomodulatori
properti
suppress
proinflammatori
cytokin
product
shown
vitro
vivo
experiment
evid
morikawa
et
al
morikawa
et
al
b
morikawa
et
al
matsumoto
et
al
matsumoto
et
al
honda
et
al
ishizaka
et
al
okabayashi
et
al
mechan
suppress
proinflammatori
cytokin
indic
inhibit
transcript
factor
nfkb
activ
play
key
role
inflammatori
respons
yoneshima
et
al
okabayashi
et
al
paf
receptor
express
also
regul
nfkb
mutoh
et
al
shimizu
mutoh
inde
nfkbspecif
inhibitor
pyrrolidin
dithiocarbam
pdtc
suppress
acidinduc
pafreceptormedi
pneumonia
adhes
respiratori
epitheli
cell
ishizuka
et
al
present
studi
examin
effect
fosfomycin
paf
receptor
express
bacteri
adhes
epitheli
cell
induc
rsv
infect
virus
cell
line
bacteria
reagent
rsv
strain
long
human
type
ii
pulmonari
epitheli
cell
line
pneumonia
strain
h
influenza
strain
rd
obtain
american
type
cultur
collect
manassa
va
clinic
isol
pneumonia
h
influenza
describ
previous
yokota
et
al
ohkoshi
et
al
rsv
grown
cell
viru
titer
rsv
determin
plaqueform
assay
use
cell
indic
okabayashi
et
al
fosfomycin
obtain
meiji
seika
kaisha
tokyo
japan
paf
receptor
antagonist
n
n
n
trimethyl
hexanolamin
purchas
calbiochemmerck
kgaa
darmstadt
germani
nfkb
inhibitor
pdtc
purchas
sigmaaldrich
st
loui
mo
isol
phosphocholinedefici
pneumonia
mutant
phosphocholinedefici
mutant
isol
serial
passag
pneumonia
strain
chemic
defin
medium
cdm
contain
decreas
concentr
ethanolamin
passag
accord
yother
et
al
briefli
approxim
cell
cultur
ml
cdm
contain
mg
ml
ethanolamin
h
dilut
medium
follow
five
passag
cdm
contain
mg
ml
ethanolamin
similar
passag
perform
success
lower
concentr
ethanolamin
mg
ml
result
mutant
capabl
growth
cdm
without
cholin
ethanolamin
cell
wall
fraction
prepar
follow
cell
grown
midlog
phase
harvest
immedi
boil
salin
contain
sd
min
boil
cell
disrupt
sonic
centrifug
g
min
pellet
wash
extens
salin
use
cell
wall
fraction
content
cholin
cell
wall
prepar
determin
use
enzymat
method
assmann
schriewer
cholin
content
cell
wall
fraction
mutant
nmol
mg
undetect
respect
cell
surfac
express
paf
receptor
examin
flow
cytometri
cell
harvest
cultur
flask
use
cell
scraper
incub
mg
ml
mous
antipaf
receptor
monoclon
antibodi
clone
cayman
chemic
ann
arbor
mi
mous
k
isotyp
control
antibodi
ebiosci
san
diego
ca
incub
min
cell
collect
centrifug
wash
dulbecco
phosphatebuff
salin
pb
cell
suspens
incub
phycoerythrinconjug
goat
antimous
igg
f
ab
fragment
antibodi
dilut
abcam
cambridg
uk
min
stain
cell
assess
facscalibur
bd
bioscienc
san
jose
ca
bacteri
suspens
mm
sodium
carbon
buffer
ph
cfu
ml
prepar
fitc
isomeri
dojindo
laboratori
kumamoto
japan
ad
concentr
mg
ml
mixtur
incub
h
cell
wash
three
time
pb
monolay
cell
infect
rsv
multipl
infect
moi
h
uninfect
cell
incub
fitclabel
pneumonia
h
influenza
cell
moi
min
experi
mg
ml
n
n
n
trimethyl
hexanolamin
mg
ml
mous
antipaf
receptor
monoclon
antibodi
clone
ad
h
addit
fitclabel
bacteria
cell
monolay
wash
three
time
pb
observ
fluoresc
microscopi
altern
cell
harvest
cell
scraper
assess
flow
cytometri
facscalibur
total
rna
prepar
cell
use
quickgen
sp
kit
rna
cultur
cell
hc
system
fujifilm
tokyo
japan
rtpcr
perform
use
one
step
rtpcr
kit
qiagen
hilden
germani
describ
previous
okabayashi
et
al
okabayashi
et
al
quantit
natur
rtpcr
valid
linear
determin
curv
obtain
variou
concentr
rna
detect
paf
receptor
mrna
carri
primer
set
result
two
group
compar
use
unpair
student
ttest
cell
infect
rsv
moi
express
paf
receptor
upregul
detect
flow
cytometri
fig
rtpcr
fig
presenc
fosfomycin
rsv
infect
rsvinduc
upregul
paf
receptor
significantli
suppress
dosedepend
manner
fig
degre
suppress
fosfomycin
slightli
less
nfkb
inhibitor
pdtc
wherea
fosfomycin
influenc
rsv
replic
pdtc
significantli
suppress
rsv
replic
fig
suppress
paf
receptor
express
also
observ
cell
posttreat
fosfomycin
h
rsv
infect
fig
uninfect
infect
rsv
infect
rsv
fom
ml
infect
rsv
fom
ml
infect
rsv
antipafr
mab
two
hour
rsv
infect
fom
mg
ml
paf
receptor
pafr
antagonist
mg
ml
antipafr
monoclon
antibodi
mg
ml
ad
cultur
cell
cell
infect
rsv
strain
long
moi
infect
fitclabel
bacteri
cell
ad
cell
monolay
moi
incub
continu
min
adher
label
bacteria
detect
flow
cytometri
black
line
gray
line
indic
cell
incub
unlabel
bacteria
experi
perform
triplic
mean
fluoresc
intens
estim
rel
valu
mean
fluoresc
intens
rsvuninfect
cell
incub
fitclabel
bacteria
calcul
graph
present
mean
rel
fluoresc
intens
ae
sd
statist
signific
p
rsvinfect
cell
without
addit
inhibitori
agent
none
fom
ml
examin
adhes
fitclabel
pneumonia
h
influenza
cell
cell
flow
cytometri
fig
rsv
infect
significantli
enhanc
pneumonia
h
influenza
adhes
cell
enhanc
suppress
addit
paf
receptor
antagonist
antipaf
receptor
monoclon
antibodi
result
indic
rsvinduc
bacteri
adhes
via
paf
receptor
cell
bacteri
adhes
strongli
suppress
mg
ml
fosfomycin
mg
ml
fosfomycin
fig
suppress
pneumonia
adhes
fosfomycin
stronger
h
influenza
adhes
similar
observ
made
fluoresc
microscop
analysi
pneumonia
fig
h
influenza
data
shown
adhes
phosphocholin
pneumonia
cell
surfac
ligand
paf
receptor
thu
examin
cell
adhes
activ
phosphocholinedefici
pneumonia
mutant
fig
adher
phosphocholinedefici
mutant
slightli
upregul
rsv
infect
compar
parent
strain
upregul
rsv
infect
significantli
suppress
presenc
fosfomycin
wherea
adhes
mutant
cell
significantli
alter
fosfomycin
treatment
result
indic
fosfomycin
suppress
pneumonia
h
influenza
adhes
paf
receptordepend
manner
via
bacteri
phosphocholin
sever
clinic
isol
pneumonia
h
influenza
also
assess
similar
rsvinduc
bacteri
adhes
signific
suppress
fosfomycin
well
paf
receptor
antagonist
occur
fig
furthermor
strain
rsv
long
yield
compar
result
upregul
paf
receptor
inhibitori
effect
fosfomycin
paf
receptor
induct
data
shown
line
evid
confirm
express
paf
receptor
induc
rsv
infect
indic
induct
suppress
fosfomycin
treatment
recent
report
fosfomycin
suppress
rsvinduc
product
chemokin
regul
activ
normal
tcell
express
secret
rant
respiratori
epitheli
cell
line
affect
viru
replic
okabayashi
et
al
suppress
chemokin
induct
rsv
due
downregul
nfkb
activ
okabayashi
et
al
yoneshima
et
al
also
report
suppress
nfkb
activ
fosfomycin
human
monocyt
cell
line
tcell
line
jurkat
stimul
gramneg
bacteri
lipopolysaccharid
paf
receptor
receptor
pneumonia
h
influenza
cundel
et
al
sword
et
al
transcript
paf
receptor
gene
control
nfkb
mutoh
et
al
shimizu
mutoh
ishizuka
et
al
show
specif
nfkb
inhibitor
pdtc
suppress
acidinduc
pneumonia
adhes
cell
via
suppress
paf
receptor
induct
henc
suppress
paf
receptor
express
fosfomycin
seem
due
suppress
nfkb
activ
respiratori
virus
includ
rsv
induc
paf
receptor
bacteri
adhes
via
ishizuka
et
al
avadhanula
et
al
present
studi
show
fosfomycin
suppress
pneumonia
h
influenza
adhes
rsvinfect
cell
bacteri
adhes
suppress
paf
antagonist
antipaf
receptor
antibodi
hand
phosphocholinedefici
pneumonia
mutant
show
rsvinduc
adhes
suppress
fosfomycin
result
indic
paf
receptor
host
phosphocholin
bacteria
interact
enhanc
rsv
infect
suppress
fosfomycin
inhibit
paf
receptor
induct
fosfomycin
effici
suppress
paf
receptor
express
rsvinduc
paf
receptordepend
bacteri
adhes
concentr
mg
ml
fig
goto
et
al
report
peak
serum
level
fosfomycin
rapid
intraven
administr
mg
kg
ae
ae
mg
ml
respect
also
peak
serum
level
fosfomycin
oral
administr
ae
ae
mg
ml
mg
kg
dose
respect
thu
fosfomycin
expect
suppress
enhanc
bacteri
adhes
rsvinduc
paf
receptor
intraven
oral
administr
clinic
appropri
dose
upregul
paf
receptor
express
enhanc
adhes
pneumonia
h
influenza
respiratori
epitheli
cell
consid
major
risk
factor
secondari
bacteri
infect
respiratori
viru
infect
propos
fosfomycin
effici
suppress
rsvinduc
paf
receptor
express
enhanc
adhes
diseasecaus
bacteria
h
influenza
rel
fluoresc
intens
fig
suppress
fosfomycin
fom
rsvinduc
adhes
cell
fitclabel
cell
streptococcu
pneumonia
strain
haemophilu
influenza
strain
b
clinic
isol
determin
flow
cytometri
two
hour
rsv
infect
fom
mg
ml
paf
receptor
pafr
antagonist
mg
ml
ad
cultur
cell
cell
infect
rsv
strain
long
moi
infect
fitclabel
bacteri
cell
ad
cell
monolay
moi
incub
continu
min
adher
label
bacteria
detect
flow
cytometri
black
line
gray
line
indic
cell
incub
unlabel
bacteria
experi
perform
triplic
mean
fluoresc
intens
estim
rel
valu
mean
fluoresc
intens
rsvuninfect
cell
incub
fitclabel
bacteria
calcul
figur
show
mean
rel
fluoresc
intens
ae
sd
statist
signific
p
rsvinfect
cell
without
addit
inhibitori
agent
none
